Gujarat Alkalies & Chemicals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹1,409 Cr (+23% YoY), EBITDA ₹222 Cr, PAT ₹79 Cr (+394%). Project Ahvaan drives cost cuts toward a ₹10K+ Cr FY31 revenue target.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
30 announcements with these filters
Q2 FY27 revenue ₹1,409 Cr (+23% YoY), EBITDA ₹222 Cr, PAT ₹79 Cr (+394%). Project Ahvaan drives cost cuts toward a ₹10K+ Cr FY31 revenue target.
Gujarat Alkalies and Chemicals appointed Dr. Brijesh Patel as Head (R&D) (GM) with effect from 5 November 2026, per the annexed Regulation 30 profile. The filing is a senior management appointment with no monetary value.
Gujarat Alkalies and Chemicals Ltd reported its highest-ever quarterly revenue of ₹1,334.79 Crore for Q2 FY27. Profit Before Tax surged 657% year-on-year to ₹102.10 Crore.
Gujarat Alkalies & Chemicals Ltd reported revenue from operations of ₹1,358 Cr (+25.3% YoY) and net profit of ₹82.6 Cr (+406.7% YoY) for Q2 FY27.
Gujarat Alkalies reported that 6.6 MW of its 75.9 MW Clean Max hybrid power project is now operative. The project is in stabilisation, and the remaining supply will follow in due course.
GACL notified a board meeting on 5 November 2026 to consider Q2 and H1 FY27 provisional results. The trading window will remain closed until 7 November 2026.
GACL conducted the ground-breaking ceremony of its 33,870 TPA food-grade phosphoric acid plant PPA-II at Dahej. The facility marks the start of construction for capacity expansion.
Gujarat Alkalies and Chemicals Limited has published newspaper advertisements regarding a special window for the transfer and dematerialization of physical securities as per SEBI regulations.
Gujarat Alkalies and Chemicals Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended 30 September 2026.
Gujarat Alkalies and Chemicals Limited conducted its 53rd Annual General Meeting on September 25, 2026. Members considered dividend declaration and approval of material related party transactions.
Gujarat Alkalies and Chemicals Limited has submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance and operational metrics.
Gujarat Alkalies and Chemicals Limited has scheduled its 53rd Annual General Meeting for September 25, 2026. Key agenda items include dividend declaration and related party transaction approvals.
Gujarat Alkalies and Chemicals Limited has informed the exchanges regarding a change in the email address of its Registrar and Share Transfer Agent, MUFG Intime.
GACL delivered strong Q1 FY27 results with revenue growing 12% and PAT surging 563% YoY. The company is undergoing a strategic transformation via 'Project Ahvaan' targeting significant revenue expansion.
Gujarat Alkalies and Chemicals Ltd received a credit rating update from CARE Ratings, including a downgrade of long-term bank facilities and reaffirmation of other instruments.
Gujarat Alkalies and Chemicals Ltd received credit ratings from CARE Ratings. Long Term Bank Facilities were downgraded to CARE AA- Stable.
Gujarat Alkalies and Chemicals Limited has scheduled its 53rd Annual General Meeting for September 25, 2026. The record date for the dividend is set for September 18, 2026.
GACL reported strong Q1 FY27 financial growth with record revenue. The Board also approved a new HCL synthesis unit at Dahej costing approximately ₹55 Crore.
Gujarat Alkalies approved the construction of an additional HCL synthesis unit at Dahej with an approximate project cost of ₹55 Crore.
Gujarat Alkalies & Chemicals Ltd reported revenue from operations of ₹1,245 Cr (+12.7% YoY) and net profit of ₹55 Cr for Q1 FY27.
Gujarat Alkalies & Chemicals will hold a Board meeting on 23 July 2026 to approve unaudited Q1 results. The trading window remains closed until 27 July 2026.
Gujarat Alkalies and Chemicals Ltd has posted an updated investor presentation on its website for shareholders. No new financial or operational changes are disclosed.
Gujarat Alkalies invested Rs.32.33 Crore in Cleanmax Sphere Energy to maintain 26% stake. The investment secures captive renewable power for its operations.
Gujarat Alkalies and Chemicals partnered with CleanMax to source renewable energy from a 75.90 MW wind and 84.34 MWp solar project. This agreement supports GACL's decarbonisation goals.
Gujarat Alkalies and Chemicals recommended a final dividend of ₹17.7 per equity share for FY2026. The record date will be announced subsequently.
Gujarat Alkalies and Chemicals approved a ₹67 Crore high-purity hydrogen peroxide plant in Dahej. The 5000 TPA facility targets semiconductor and solar cell manufacturing sectors.
Gujarat Alkalies & Chemicals Ltd reported revenue from operations of ₹1,125 Cr (+4.6% YoY) and net profit of ₹15 Cr (+70.5% YoY) for Q4 FY26.
Gujarat Alkalies and Chemicals reported FY2025-26 audited financial results and recommended a 177% dividend. The Board also approved a new hydrogen peroxide plant at Dahej.
Gujarat Alkalies scheduled a board meeting for May 29, 2026, to approve audited financial results. Directors will also consider a dividend recommendation for shareholders.
Gujarat Alkalies and Chemicals submitted its Annual Secretarial Compliance Report for FY 2025-26. The report confirms compliance with SEBI regulations with no adverse observations reported.